Serum Inflammation-based Scores in Endocrine Tumors

Area of Science:

• Endocrinology
• Oncology
• Inflammation Research

Background:

• Serum inflammation-based scores assess systemic inflammation and nutritional status, predicting cancer outcomes.
• Their clinical utility in endocrine tumors remains less understood compared to other cancers.

Purpose of the Study:

• To review the current knowledge on serum inflammation-based scores in endocrine tumors.
• To evaluate their role in predicting tumor phenotype, aggressiveness, and prognosis.

Main Methods:

• A comprehensive PubMed search was conducted using specific keywords related to endocrine tumors and inflammation scores.
• Included studies investigated various serum inflammation-based scores in endocrine tumor patients.

Main Results:

• Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are the most studied scores in endocrine tumors.
• These scores show potential in stratifying risk and identifying aggressive or refractory disease, especially post-surgery.

Conclusions:

• The value of serum inflammation-based scores in managing endocrine tumors is emerging.
• Further research is needed to validate specific markers and cut-offs for routine clinical practice.